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Aim  of the  study:  This  study  investigated  the incidence  of  hyperﬁbrinolysis  upon  emergency  department
(ED)  admission  in patients  with  out  of hospital  cardiac  arrest  (OHCA),  and  the  association  of the  degree
of hyperﬁbrinolysis  with  markers  of hypoperfusion.
Methods:  From  30 OHCA  patients,  cardiopulmonary  resuscitation  (CPR)  time,  pH, base  excess  (BE),  and
serum lactate  were  measured  upon  ED  admission.  A 20%  decrease  of rotational  thromboelastometry
maximum  clot  ﬁrmness  (MCF)  was  deﬁned  as  hyperﬁbrinolysis.  Lysis  parameters  included  maximum
lysis  (ML),  lysis  onset  time  (LOT)  and  lysis  index  at 30 and  45  min  (LI30/LI45).  The study  was  approved
by  the Human  Subjects  Committee.
Results:  Hyperﬁbrinolysis  was  present  in  53%  of patients.  Patients  with  hyperﬁbrinolysis  had  longer
median  CPR  times  (36  (15–55)  vs. 10 (7–18)  min;  P  = 0.001),  a prolonged  activated  partial  thromboplastin
time  (54  ±  16  vs. 38 ±  10  s; P = 0.006)  and  elevated  D-dimers  (6.1  ± 2.1 vs. 2.3  ±  2.0  g/ml;  P  =  0.02)  when
compared  to  patients  without  hyperﬁbrinolysis.  Hypoperfusion  markers,  including  pH  (6.96  ±  0.11  vs.
7.17 ± 0.15; P  <  0.001),  base  excess  (−20.01  ±  3.53  vs. −11.91  ± 6.44;  P  <  0.001)  and  lactate  (13.1 ±  3.7 vs.
8.0  ± 3.7  mmol/l)  were  more  disturbed  in patients  with  hyperﬁbrinolysis  than  in  non-hyperﬁbrinolytic
subjects, respectively.  The  LOT  showed  a good  association  with  CPR  time  (r  = −0.76;  P  = 0.003)  and  lac-
tate  (r  =  −0.68;  P =  0.01),  and  was  longer  in  survivors  (3222  ± 34 s) than  in non-survivors  (1356  ±  833;
P  =  0.044).
Conclusion:  A  substantial  part  of  OHCA  patients  develop  hyperﬁbrinolysis  in  association  with markers
for  hypoperfusion.  Our  data  further  suggest  that  the  time  to  the onset  of clot  lysis  may  be an  important
marker  for the  severity  of  hyperﬁbrinolysis  and  patient  outcome.. Introduction
Out-of-hospital cardiac arrest (OHCA) remains a signiﬁcant
ause of morbidity and mortality among the general population.
espite advances in cardiopulmonary resuscitation, the prognosis
fter OHCA remains very poor, with survival rates around 10% in
urope.1
Cardiac arrest and resuscitation are characterised by reduced
ardiac output and blood ﬂow, resulting in shock and tissue
ypoperfusion.2–4 Animal and human studies showed marked
ctivation of inﬂammation and coagulation after cardiac arrest
 A Spanish translated version of the abstract of this article appears as Appendix
n  the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2012.05.008.
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and resuscitation, resulting in intravascular coagulation, systemic
formation of microthrombi and impairment of microcirculatory
perfusion.5–7 These changes may  contribute to the development
of ischemic injury and the post-resuscitation syndrome, which is
further characterised by a systemic inﬂammation response, reper-
fusion injury, adrenal dysfunction, myocardial dysfunction and
eventually organ failure.8,9 In particular, an increased duration of
cardiopulmonary resuscitation is associated with a rise in coagula-
tion abnormalities and mortality.8,10
Recent studies have shown that markers of shock and
hypoperfusion in trauma patients are frequently paralleled by
hyperﬁbrinolysis, which in turn is associated with higher mortality
rates.11–13 One of the proposed mechanisms is that hypoperfusion-
associated thrombin formation leads to systemic hyperﬁbrinolysis
Open access under the Elsevier OA license.through the protein C pathway, but the underlying mechanisms are
not well understood.11,12,14 Secondly, hypoxia may lead to exces-
sive release of tissue plasminogen activator (t-PA) and thereby
contribute to the presence of hyperﬁbrinolysis.15
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Despite the close resemblance of systemic hypoperfusion
s observed during trauma, sepsis or OHCA, there is only
imited evidence showing that OHCA patients develop hyper-
brinolysis. Moreover, it has never been investigated whether
brinolytic parameters, like the maximum lysis or lysis onset
ime, are indeed associated with markers for hypoperfusion. In
he present study we therefore investigated whether cardiopul-
onary arrest is associated with hyperﬁbrinolysis as diagnosed by
otational thromboelastometry, and hypothesised that the sever-
ty of hyperﬁbrinolysis is associated with the degree of shock and
ypoperfusion.
. Methods
.1. Patient population
The present study comprised a prospective observational clin-
cal study that included patients admitted to the shock room of
he emergency department (ED) after out of hospital cardiac arrest
OHCA) who were monitored by rotational thromboelastometry
ccording to standard clinical routine. The study was  performed
ccording to the regulations of the Human Subjects Committee.
atients aging 18 years and older who had a witnessed out-of-
ospital cardiac arrest that was not related to trauma were included
n the study. Exclusion criteria were the inability to drawn blood
amples, previous haemostatic abnormalities, traumatic arrest,
regnancy, cardiac arrest from septic shock, the use of heparin or
arfarins and/or suspected (massive) pulmonary embolism.
.2. Study parameters
Data included patient characteristics, the transportation time
etween arrest and arrival at the emergency department, initial
eart rhythm on site recorded by the ambulance paramedic, the
uration of chest compressions, the heart rhythm upon arrival
t the emergency department, haemoglobin, haematocrit, arterial
xygen partial pressure (pO2), arterial carbon dioxide partial pres-
ure (pCO2), base excess (BE), pH and serum lactate.
.3. Blood sampling
Blood sampling was performed as soon as possible after patient
dmission to the emergency department. Blood sampling took
lace either before or after return of spontaneous circulation
ROSC) from a single arterial puncture, which is routine practice
n our trauma centre. All coagulation tests were performed within
0 min  after blood sampling.
.4. Coagulation parameters
All routine coagulation tests were performed in the haemostasis
aboratory of the VU University Medical Centre using standardised
easurements. Samples were centrifuged for 10 min  at 4000 rpm
nd subsequently centrifuged for another 5 min  at 12,000 rpm. The
outine coagulation tests consisted of the prothrombin time (PT)
sing calcium thromboplastin, the activated partial thromboplas-
in time (aPTT) using cefaline/microcrystaliline and platelet count.
he aPTT and PT tests were performed using a STA-R instrument®
Roche Diagnostics FmbH, Basel, Switzerland).
Rotational thromboelastometry (TEM International, Munich,
ermany) consisted of a 60-min registration of the EXTEM test
measurement of thromboplastin-induced activation of the coag-
lation). ROTEM parameters included the clotting time (CT), clot
ormation time (CFT), maximum clot ﬁrmness (MCF), maximum
ysis (ML), lysis time (LT) and lysis onset time (LOT) (Fig. 1).n 83 (2012) 1451– 1455
2.5. Deﬁnition of hyperﬁbrinolysis
Hyperﬁbrinolysis was deﬁned as a maximum lysis of the clot
of >20% within 60 min  following initiation of rotational thromboe-
lastometry in the EXTEM channel. The maximum lysis index (ML)
is the difference between the maximum MCF  and the lowest MCF
due to ﬁbrinolysis and is described as percentage. The lysis onset
time (LOT) is the time from the start of the reaction to the point
that a lysis of 20% from the MCF  is reached. The lysis index at
30 and 45 min  (LI30 and LI45, respectively) represent the remain-
ing clot ﬁrmness amplitude at 30 and 45 min  after the start of
the reaction relative to the maximal clot ﬁrmness. The lysis time
(LT) is the time from when the MCF  is reached until maximum
lysis.
2.6. Statistical analysis
Data were stored in the hospital electronic medical database
(Mirador® iSOFT Nederland). Statistical analysis was performed
using the SPSS statistical software package 17.0 (IBN, New York,
USA). Descriptive statistics were calculated for all parameters and
included mean, median with standard deviation, frequencies or
median with interquartile range. Statistical differences between
patients with or without hyperﬁbrinolysis were calculated using
a Student’s T-test or Mann–Whitney U test. Pearson correlations
were used to determine the association between several labora-
tory values and ﬁbrinolytic parameters. A P-value of 0.05 or less
was considered as statistically signiﬁcant.
3. Results
3.1. Patient characteristics
The study included 30 patients with witnessed out of hospital
cardiac arrest that were admitted to the emergency department of
the VU University Medical Center after witnessed out-of-hospital
cardiac arrest between November 2009 and May 2010. Three
patients were excluded due to suspected pulmonary embolism,
eight patients were not included since no blood sample could
be drawn and one patient was included due to missing coagula-
tion data. The remaining 30 patients were 66 ± 15 years old and
64% were male. The mean time from witnessed cardiopulmonary
arrest to emergency department arrival was 42 ± 13 min. The mean
duration of cardiopulmonary resuscitation was  27 ± 22 min. The
number of patients with ﬁrst rhythm ventricular ﬁbrillation was
53%.
Table 1 shows the characteristics of patients without or with
hyperﬁbrinolysis. In the total study group, 16 patients out of 30
patients (53%) developed hyperﬁbrinolysis. The median chest com-
pression time (ALS) and median time to ﬁrst cardiac output was
higher in patients with hyperﬁbrinolysis (36 (15–55) min  and 44
(33–58) min, respectively) than patients without hyperﬁbrinoly-
sis (10 (7–18) min  and 16 (13–28) min, respectively). Patients with
hyperﬁbrinolysis had signs of disseminated intravascular coagu-
lopathy as indicated by the higher aPTT (54 ± 16 s vs. 38 ± 10 s) and
D-dimers (6.1 ± 2.1 g/ml vs. 2.3 ± 2.0 g/ml) when compared to
patients without hyperﬁbrinolysis, respectively.
Hyperﬁbrinolysis was associated with markers of hypoperfu-
sion as indicated by pH, base excess, lactate, pO2 and pCO2 (Table 1).
In particular, base excess (−11.91 ± 6.44 vs. −20.01 ± 3.53;
P < 0.001) and lactate (8.0 ± 3.7 ± 13.1 ± 3.7; P = 0.001) levels
differed signiﬁcantly between patients without or with hyperﬁbri-
nolysis, respectively.
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Table 1
Characteristics of patients without or with hyperﬁbrinolysis.
No hyperﬁbrinolysis Hyperﬁbrinolysis P
N 14 16
Age (years) 65 ± 18 68 ± 13 ns
Resuscitation parameters
Median transportation time (min) 44 (34–49) 38 (32–53) ns
Median CPR time (min) 10 (7–18) 36 (15–55) 0.001
Median time to 1st output (min) 16 (13–28) 44 (33–58) 0.007
Coagulation parameters
Haemoglobin (mmol/l) 8.3 ± 1.0 8.5 ± 1.2 ns
Haematocrit 0.41 ± 0.05 0.43 ± 0.06 ns
aPTT  (s) 38 ± 10 54 ± 16 0.006
INR  1.55 ± 1.03 2.04 ± 1.42 ns
Platelet count (10−9)* 217 ± 92 186 ± 90 ns
Fibrinogen (g/l) 3.4 ± 1.0 1.9 ± 1.4 ns
D-dimers (g/ml) 2.3 ± 2.0 6.1 ± 2.1 0.02
Markers for hypoperfusion
pH 7.17 ± 0.15 6.96 ± 0.11 <0.001
BE −11.91 ± 6.44 −20.01 ± 3.53 <0.001
Lactate (mmol/l) 8.0 ± 3.7 13.1 ± 3.7 0.001
Median pO2 (kPa) 237 (127–405) 92 (54–124) 0.001
Median pCO2 (kPa) 44 (35–52) 59 (46–78) 0.03
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.2. Relation hyperﬁbrinolysis parameters and markers of
ypoperfusion
In patients with hyperﬁbrinolysis, the lysis index of the EXTEM
t 30 and 45 min  estimated 72 ± 43% and 56 ± 42%, respectively. The
ysis onset time was 1798 ± 970 s, with a lysis time of 1487 ± 1159 s.
verall, the lysis onset time ranged from 514 to 2947 s. The max-
mum lysis was 64 ± 39%. Fig. 2 show the association of the lysis
nset time with cardiopulmonary resuscitation (CPR) time (panel
), base excess (panel B) and lactate levels (panel C). The lysis onset
ime showed a good correlation with the CPR time and lactate lev-
ls. Lactate, and not base excess, was overall associated with the
aximum lysis (r = 0.52; P = 0.04), LI30 (r = −0.61; P = 0.01) and LI45
r = −0.87; P < 0.001).
.3. Patient outcome
In the total group, 19 patients (63%) died after hospital admis-
ion. The study was not powered to compare mortality in patients
ith or without hyperﬁbrinolysis. Overall, mortality in patients
ith or without hyperﬁbrinolysis estimated 69% and 57%, respec-
ively. Patients with hyperﬁbrinolysis who died showed a shorter
ysis onset time (1356 ± 833 s) when compared to survivors with
yperﬁbrinolysis (3222 ± 34 s; P = 0.044).
ig. 1. ROTEM lysis parameters: MCF, maximum clot formation, LOT, lysis onset
ime, LT, lysis time, LI30, lysis index at 30 min, LI45, lysis index at 45 min, ML,
aximum lysis.nary resuscitation; aPTT, activated partial thromboplastin time; INR, international
; pCO2, arterial carbon dioxide pressure; ns, not signiﬁcant.
4. Discussion
This is the ﬁrst clinical study showing hyperﬁbrinolysis using
rotational thromboelastometry in a majority of the patients admit-
ted after witnessed out of hospital cardiac arrest. Hyperﬁbrinolysis
was associated with profound disseminated intravascular coagu-
lopathy compared to patients without hyperﬁbrinolysis. The most
interesting marker for hyperﬁbrinolysis was the lysis onset time,
which was  related to the cardiopulmonary resuscitation time and
lactate levels. A delayed start of hyperﬁbrinolysis was less fre-
quently associated with markers for hypoperfusion and mortality.
Our study shows that a signiﬁcant part of out of hospital cardiac
arrest patients develop hyperﬁbrinolysis, in particular in case of
signs of hypoperfusion. This supports the hypothesis that hyper-
ﬁbrinolysis may  be induced by shock and hypoperfusion solely,
without the presence of trauma or massive blood loss.
Primary ﬁbrinolysis is a local tissue phenomenon that supports
blood clot breakdown. Under physiological conditions, ﬁbrinol-
ysis is activated by urokinase or tissue plasminogen activator
(tPA) that is released by the damaged endothelium. Urokinase
and tPA are inhibited by plasminogen activator inhibitor (PAI) 1
or 2. After conversion of plasminogen to plasmin, plasmin is pri-
mary inhibited by alpha-2-antiplasmin, while thrombin activatable
ﬁbrinolysis inhibitor (TAFI) further inhibits ﬁbrinolysis itself.15–17
Secondary ﬁbrinolysis refers to an abnormal clot breakdown under
pathophysiological circumstances, like trauma or disturbances in
tissue perfusion, which may  confer to hyperﬁbrinolysis. One of
the proposed mechanisms underlying excessive ﬁbrinolysis is the
activation of protein C, which subsequently inhibits PAI-1 and
TAFI.10,12,14 Moreover, hypoxia induces a systemic release of t-PA,
leading to excessive ﬁbrinolysis.15,18,19 Our ﬁndings warrant closer
evaluation of levels of t-PA, activated protein C, plasminogen, PAI
and TAFI in OHCA patients in order to understand the pathophysi-
ology of hyperﬁbrinolysis during cardiopulmonary arrest.
Cardiac arrest and resuscitation have previously been shown
to be associated with activation of coagulation and inﬂammation
that closely resembled the changes observed in sepsis. Adrie et al.
showed that patients who were successfully resuscitated after car-
diopulmonary arrest had a systemic inﬂammatory response with
activation of coagulation, reduction of anticoagulation, activation of
1454 V.A. Viersen et al. / Resuscitatio
Fig. 2. Pearson correlations (r) between lysis onset time and cardiopulmonary
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brinolysis and in some cases inhibition of ﬁbrinolysis.10 In particu-
ar, hyperﬁbrinolysis was associated with increased early mortality,
ut the authors did not look further into the association between
he degree of shock and the level of hyperﬁbrinolysis.10 In agree-
ent with their study, we found that about 50% of the patients
ith cardiopulmonary arrest developed hyperﬁbrinolysis.10 More-
ver, we found a good correlation between chest compression
ime and lactate with the onset time of hyperﬁbrinolysis, sug-
esting an association between hypoperfusion and excessive
brinolysis in OHCA patients. However, even though mean pH,
E and lactate levels were higher in the group of patients with
yperﬁbrinolysis, patients in the non-hyperﬁbrinolysis group also
uffered from severe metabolic acidosis. Further studies are nec-
ssary to unravel the involvement of endothelial activation, t-PA
elease and the inhibition of PAI and TAFI in order to gain more
nsight in the cause of hyperﬁbrinolysis in patients with cardiac
rrest.n 83 (2012) 1451– 1455
This is the ﬁrst study that uses rotational thromboelastometry
to diagnose hyperﬁbrinolysis in the patients with cardiopulmonary
arrest. Hyperﬁbrinolysis is not detectable by classical haemostatic
testing such as the aPTT or PT. Schöchl et al. were the ﬁrst to show
that trauma patients with hyperﬁbrinolysis as measured by throm-
boelastometry were at higher risk for unfavourable outcome.11
Interestingly, they also detected hyperﬁbrinolysis in a small group
of patients with isolated traumatic brain injury in the absence of
extracranial haemorrhage, suggesting that excessive bleeding is
no prerequisite for hyperﬁbrinolysis.20 As the number of hospi-
tals with point-of-care coagulation testing increases, more insight
might be obtained of the association between out of hospital cardiac
arrest and hyperﬁbrinolysis.
There is currently no consensus with respect to the validity of
the ﬁbrinolytic parameters provided by rotational thromboelas-
tometry. Moreover, it is unclear whether the level or the onset time
of ﬁbrinolysis is more important to determine the severity level of
hyperﬁbrinolysis. Most studies use the maximum lysis index (ML),
which shows the extent of lysis as percentage of the maximum clot-
ting amplitude (MCF) after 60 min  of runtime. In particular, Schöchl
et al. used a categorical classiﬁcation for late, intermediate and ful-
minant hyperﬁbrinolysis.11 The solely use of the ML  may  lead to an
underestimation of the degree of hyperﬁbrinolysis in cases where
a maximum lysis is reached before 60 min  of runtime. We  there-
fore used the lysis onset time (LOT) as the point where the decline
in clot ﬁrmness starts. Theoretically, this parameter seems most
appropriate for determining the degree of hyperﬁbrinolysis as it
provides a measure for hyperﬁbrinolysis for every patient with clot
lysis within 60 min  of ROTEM runtime. Moreover, in contrast to the
maximum lysis, the LOT has no maximum. The choice for the LOT  in
our study matches with previous ex vivo research by Nielsen et al.,
who showed a relation between increasing tPA concentrations and
the time to clot disintegration.21 Further studies are necessary to
validate the use of the lysis onset time to quantify the degree of
hyperﬁbrinolysis.
Our investigation did not include body temperature regis-
trations of included patients. As hypothermia may  deteriorate
coagulation, our ﬁndings might be confounded in case of low body
temperature. Part of our study population received prehospital ﬂu-
ids up to 500 ml,  but these data were also not included in our study
database. It is however not expected that the ﬂuid administration
did affect the time to hyperﬁbrinolysis in our study population.
This study was  not powered to determine differences in outcome
between patients with or without hyperﬁbrinolysis, and no con-
clusions may  be drawn from these data regarding ﬁnal outcome.
However from the seven patients with unfavourable outcome in
the emergency room, six patients showed hyperﬁbrinolysis. On one
hand, this may  suggest that excessive ﬁbrinolysis is associated with
early death, although larger studies are warranted to support this
concept. On the other hand, a state of hyperﬁbrinolysis may  the-
oretically be beneﬁcial in patients in severe shock by maintaining
vascular patency and end-organ perfusion. The question remains
whether hyperﬁbrinolysis in patients with cardiopulmonary arrest
is an evolutionary end-of-life indicator or a physiological phe-
nomenon to prevent further ischemic and thromboembolic injury
and ensure end-organ perfusion under stressful conditions.
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